Scalable Synthesis of a Dual TLR7/8 Agonist via Highly Selective <i>N</i> 2-Alkylation of 1 <i>H</i> -Pyrazolo[4,3- <i>d</i> ]pyrimidine
We report a scalable synthesis of a potent dual TLR7/8 agonist featuring a pyrazolopyrimidine core. An acid-mediated selective <i>N</i>2-alkylation of 1<i>H</i>-pyrazolo[4,3-<i>d</i>]pyrimidine with free benzyl alcohol furnishes the <i>N</i>2-alkylated product in 72% yield with high regioselectivity (14:1 <i>N</i>2/<i>N</i>1). Subsequent copper-catalyzed amination with aqueous ammonia installs the <i>C</i>5 amino group in 70% yield, avoiding azides or complex ammonia surrogates. The convergent sequence proceeds in 34% overall yield from readily available materials and is amenable to kilogram-scale production.
Authors
- Kai‐Jiong Xiao (ORCID: https://orcid.org/0000-0001-5613-2035)
- Yingju Xu (ORCID: https://orcid.org/0000-0002-1984-9501)
- Lu Chen (ORCID: https://orcid.org/0000-0002-8097-2699)
- Zhenhua Wu (ORCID: https://orcid.org/0000-0003-4552-883X)
- Steven P. Miller (ORCID: https://orcid.org/0000-0001-8615-274X)
- Weijie Fang
- Jingjun Yin
Institutions
- Merck & Co., Inc., Rahway, NJ, USA (United States) (US)
- United States Military Academy (US)
- Pharmac (NZ)
- Changzhou University (CN)
Publication Details
- Journal
- Organic Letters
- Published
- 2025-10-31
- DOI
- https://doi.org/10.1021/acs.orglett.5c04092
- Primary Topic
- Click Chemistry and Applications
- Type
- article
- Field-Weighted Citation Impact
- 0.00